KRAS and lung cancer: Moreover, DHHC20 knockdown in both SW1573 and NCI-H23 cells decreased the IC50 concentrations of BKM120, suggesting that loss of DHHC20 sensitizes Kras-mutant lung cancers to PI3K inhibitors [40].